Spectrum of α-thalassemia mutations in transfusion-dependent β-thalassemia patients from the eastern province of Saudi Arabia

Hemoglobin

Volumn 37, Issue 1, 2013, Pages 65-73

  Akhtar, Mohammed Shakil ^a   Qaw, Fuad ^a   Francis Borgio, J ^a   Albuali, Waleed ^b   Suliman, Ahmed ^b   Nasserullah, Zaki ^b   Al Jarrash, Sana ^c   Al Ali, Amein ^a,b  

^a IMAM ABDULRAHMAN BIN FAISAL UNIVERSITY   (Saudi Arabia)

^b KING FAISAL UNIVERSITY   (Saudi Arabia)

^c Maternity and Children Hospital   (Saudi Arabia)

Author keywords

Thalassemia ( thal); Thalassemia ( thal); Mutation; Polymorphism; Saudi Arabia

Indexed keywords

ALANINE AMINOTRANSFERASE; ALPHA GLOBULIN; ASPARTATE AMINOTRANSFERASE;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ALLELE; ALPHA THALASSEMIA; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BETA THALASSEMIA; BLOOD TRANSFUSION; CODON; DNA POLYMORPHISM; FEMALE; GENE DELETION; GENE MUTATION; GENOTYPE; HETEROZYGOSITY; HOMOZYGOSITY; HUMAN; LEUKOCYTE; MAJOR CLINICAL STUDY; MALE; OSTEOPOROSIS; PHENOTYPE; SAUDI ARABIA; SPLENECTOMY;

ALPHA-GLOBINS; ALPHA-THALASSEMIA; BETA-THALASSEMIA; BLOOD TRANSFUSION; FEMALE; GENE FREQUENCY; GENOTYPE; HETEROZYGOTE; HOMOZYGOTE; HUMANS; MALE; MUTATION; SAUDI ARABIA;

EID: 84872142042     PISSN: 03630269     EISSN: 1532432X     Source Type: Journal    
DOI: 10.3109/03630269.2012.753510     Document Type: Article

References (38)

1. Harteveld CL, Higgs DR. α-Thalassemia. Orphanet J Rare Dis. 2010;5:13.
2. Hardison RC, Chui DH, Giardine B, et al. HbVar: a relational database of human hemoglobin variants and thalassemia mutations at the globin gene server. Hum Mutat. 2002;19(3):225-233 (http://globin. csu.pse.edu). (Pubitemid 34195183)
3. El-Hazmi MA. α-Thalassemia in Saudi Arabia: deletion pattern. Hum Genet. 1987;76(2):196-198.
4. Al-Awamy BH. Thalassemia syndromes in Saudi Arabia: meta-analysis of local studies. Saudi Med J. 2000;21(1):8-17.
5. Nasserullah Z, Al Jame A, Abu Srair H, et al. Neonatal screening for sickle cell disease, glucose-6-phosphate dehydrogenises deficiency and α thalassemia in Qatif and Al Ahsa. Ann Saudi Med. 1998; 18(4):289-292. (Pubitemid 29319908)
6. Nasserullah Z, Alshammari A, Al Abbas M, et al. Regional experience with newborn screening for sickle cell disease, other hemoglobinopathies and G6PD deficiency. Ann Saudi Med. 2003;23(6):354-357. (Pubitemid 37527004)
7. Hellani A, Fadel E, El-Sadadi S, et al. Molecular spectrum of α-thalassemia mutations in microcytic hypochromic anemia patients from Saudi Arabia. Genet Test Mol Biomarkers. 2009;13(2):219-221.
8. Al-Awamy BH, Niazi GA, Naeem MA, Wilson JB, Huisman THJ. Hemoglobin Handsworth or α218(A16) Gly!Argβ2 in a Saudi newborn. Hemoglobin. 1985;9(2):183-186.
9. Rund D, Filon D, Oppenheim A, Abramov A. Silent carrier β-thalassaemia due to a severe β-globin mutation interacting with other genetic elements. Eur J Pediatr. 1993;152(7):574-576. (Pubitemid 23179181)
10. Oron V, Filon D, Oppenheim A, Rund D. Severe thalassemia intermedia caused by interaction of homozygosity for α-globin gene triplication with heterozygosity for β0-thalassaemia. Br J Haematol. 1994;86(2):377-379. (Pubitemid 24199005)
11. Muncie HL Jr, Campbell JS. α And β thalassemia. Am Fam Physician. 2009;80(4):339-344.
12. Al-Sultan A, Phanasgoankar S, Suliman A, Al-Baqushi M, Nasrullah Z, Al-Ali A. Spectrum of β-thalassemia mutations in the Eastern Province of Saudi Arabia. Hemoglobin. 2011;35(2):125-134.
13. Chong SS, Boehme CD, Higgs DR, Cutting GR. Single-tube multiplex-PCR screen for common deletional determinants of α-thalassemia. Blood. 2000;95(1):360-362. (Pubitemid 30017265)
14. Qadri MI, Islam SA. Hemoglobin H disease in the eastern region of Saudi Arabia. Saudi Med J. 2000; 21(7):666-671.
15. Kanavakis E, Wainscot JS, Wood WG, et al. The interaction of α thalassaemia and heterozygous β thalassaemia. Br J Haematol. 1982;52(2):465-473.
16. Hassan SM, Nishat H, Al-Lawatiya FJ, et al. Extended molecular spectrum of β-and α-thalassemia in Oman. Hemoglobin. 2010;34(2):127-134.
17. Tan JAMA, Lee PC, Wee YC, et al. High prevalence of α-and β-thalassemia in Kadazandusuns in East Malaysia: challenges in providing effective health care for an indigenous group. J Biomed Biotechnol. 2010;2010. doi:pii: 706872. Epub 2010 Sep 5.
18. Lau YL, Chan L, Chan YYA, et al. Prevalence and genotypes of α and β thalassemia carriers in Hong Kong-implementation for population screening. New Engl J Med. 1997;336(18):1298-1301. (Pubitemid 27187783)
19. Xu XM, Zhou YQ, Luo GX, et al. The prevalence and spectrum of α and β thalassemia in Guangdong Province: implications for the future health burden and population screening. J Clin Pathol. 2004; 57(5):517-522. (Pubitemid 38621798)
20. Li D., Liao C, Li J, et al. Detection of α-thalassemia in β-thalassemia carriers and prevention of Hb Bart's hydrops fetalis through prenatal screening. Haematologica. 2006;91(5):649-651. (Pubitemid 43799461)
21. Kalotychou V, Tzanetea R, Konstantopoulos K, Papassotiriou I, Rombos I. Erythrocytosis due to a combination of the high oxygen affinity hemoglobin variant, Hb Olympia [β20(B2)Val!Met] with β-and α-thalassemia mutations: first case in the literature. Hemoglobin. 2010;34(4):383-388.
22. Nava MP, Ibarra B, Magaña MT, Chavez ML, Perea FJ. Prevalence of-α3.7 and αααanti3.7 alleles in sickle cell trait and β-thalassemia patients in Mexico. Blood Cells Mol Dis. 2006;36(2):255-258.
23. Mast KJ, Hammond S, Qualman SJ, Kahwash SB. The coinheritance of β-and α-thalassemia: a review of one patient and her family. Lab Hematol. 2009;15(3):30-33.
24. Al-Jaouni SK. Prevalence of thalassemia disorders and hemoglobinopathies in Jeddah, Western Saudi Arabia. J Appl Hematol. 2010;1(1):43-46.
25. Acquaye J, Ganeshaguru K, Sejeny SA, et al. A study of thalassaemia families in Western Saudi Arabia. J Trop Geogr Med. 1985;37(4):319-327. (Pubitemid 16227233)
26. Sejeny S, Ganeshaguru K, Samuel A, et al. The diagnosis value of globin biosynthesis in thalassemia. Saudi Med J. 1985;6(7):546-553. (Pubitemid 16254235)
27. Niazi G, Rowland H. Haemoglobinopathies-a review. Saudi Med J. 1989;10(5):340-352.
28. El-Hami MA. Haemoglobinopathies, thalassaemias and enzymopathies in Saudi Arabia: the present status. Acta Haematol. 1987; 78(2-3):130-134.
29. Ankra-Badu GA, Al-Jama A, Al Vadim Y. Hemoglobin H disease in the Al-Qatif region of Saudi Arabia. Ann Saudi Med. 2012;21(5-6):308-311.
30. Al-Hamdan NA, Al-Mazrou Y, Al-Swaidi F, Choudhry AJ. Premarital screening for thalassemia and sickle cell disease in Saudi Arabia. Genet Med. 2007;9(6):372-377. (Pubitemid 46956479)
31. Al Shahrani M. Steps toward the prevention of hemoglobinopathies in the Kingdom of Saudi Arabia. Hemoglobin. 2009;33(Suppl 1):S21-S24.
32. El-Kalla S, Basal E. α-Thalassemia in the United Arab Emirates. Acta Haematol. 1998;100(1):49-53.
33. Jassim N, Al-Arrayed S, Gérard N, et al. Molecular basis of α-thalassemia in Bahrain. Bahrain Med Bull. 2001;23(1):3-7.
34. Adekile AD, Gu L-H, Baysal E, et al. Molecular characterization of α-thalassemia determinants, β-thalassemia alleles, and βS haplotypes among Kuwaiti Arabs. Acta Haematol. 1994;92(4):176-181.
35. Giboney PT. Mildly elevated liver transaminase levels in the asymptomatic patient. Am Fam Physician. 2005;71(6):1105-1110. (Pubitemid 40395670)
36. Nyblom H, Berggren U, Balldin J, Olsson R. High AST/ALT ratio may indicate advanced alcoholic liver disease rather than heavy drinking. Alcohol Alcohol. 2004;39(4):336-339. (Pubitemid 38968090)
37. Sripichai O, Munkongdee T, Kukkhaek C, Vasti S, Winichagoon P, Fucharoen S. Coinheritance of the different copy numbers of α-globin gene modifies severity of β-thalassemia/Hb-E disease. Ann Hematol. 2008;87(5):375-379.
38. Voon HP, Vadolas J. Controlling α-globin: a review of α-globin expression and its impact on β-thalassemia. Haematologica. 2008;93(12):1868-1876.